AMYLOID

Clinical trials for AMYLOID explained in plain language.

Never miss a new study

Get alerted when new AMYLOID trials appear

Sign up with your email to follow new studies for AMYLOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for hard-to-treat amyloidosis patients with prior daratumumab exposure

Disease control Ongoing

This study tests a combination of three drugs (daratumumab, pomalidomide, and dexamethasone) in 15 adults with AL amyloidosis whose disease has returned or not responded after prior treatment including daratumumab. The goal is to see if this triple therapy leads to more complete …

Matched conditions: AMYLOID

Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

AMYLOID

Get alerted when new AMYLOID trials appear

New hope for hard-to-treat amyloidosis patients with prior daratumumab exposure